Business Context and Reporting Period
Company: Herbalife Ltd.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2007
Business Overview: Herbalife is a global network marketing company selling weight management, nutritional supplements, energy & fitness, and personal care products through over 1.6 million independent distributors in 65 countries. In China, the company utilizes a retail store and employed sales force model due to regulatory restrictions.
Key Financial Metrics
| Metric (in millions) | Three Months Ended Sep 30, 2007 | Nine Months Ended Sep 30, 2007 |
|---|---|---|
| Net Sales | $529.5 | $1,567.7 |
| Gross Profit | $423.7 | $1,243.2 |
| Operating Income | $78.3 | $227.5 |
| Net Income | $48.3 | $137.6 |
| Diluted EPS | $0.67 | $1.87 |
| Cash from Operating Activities | N/A | $195.0 |
| Cash and Cash Equivalents (Sep 30, 2007) | $160.8 | |
| Total Debt (Long-term + Current) | $233.3 |
Note: Gross margin was 80.0% for the three months and 79.3% for the nine months ended September 30, 2007.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 11.1% for the quarter and 12.1% for the nine-month period compared to 2006. Growth was driven by strong performance in the U.S., China, Taiwan, Italy, and Spain.
- Profitability: Net income increased significantly (82.6% for the quarter and 35.6% for the nine months). This was primarily due to sales growth, expanded operating margins, and a substantial reduction in interest expense following debt refinancing in July 2006.
- Interest Expense: Net interest expense dropped to $2.7 million for the quarter and $7.2 million for the nine months, compared to $25.9 million and $36.8 million in the prior year periods. The 2006 figures included $22.9 million in costs related to the redemption of 9 1/2% Notes and repayment of the prior credit facility.
- Geographic Performance:
- Greater China: Net sales surged 42.8% (quarter) and 50.7% (nine months), driven by the expansion of direct selling licenses in Jiangsu province.
- North America: Sales grew 20.3% (quarter) and 23.4% (nine months), aided by new supervisor growth and the "Nutrition Club" distributor model.
- Brazil & Mexico: Experienced declines in sales volume and new supervisor recruitment as the company focused on compliance and restructuring distributor practices.
Guidance, Outlook, and Risks
- Share Repurchases: The Board authorized an additional $150 million to the share repurchase program in August 2007, bringing the total authorized amount to $450 million. The company repurchased approximately 1.7 million shares in Q3 2007 at an average cost of $39.23 per share.
- Dividends: The company initiated a regular quarterly cash dividend program in Q2 2007 ($0.20/share). A third-quarter dividend of $0.20/share was declared in October 2007.
- Restructuring: In October 2007, the company initiated the second phase of its "Realignment for Growth" plan, expecting to incur $8 million to $10 million in severance and employee-related costs over the next nine months.
- Legal & Regulatory Risks:
- SEC Inquiry: The company is cooperating with an SEC investigation regarding the timing of trading in Herbalife securities by a former mid-level employee and a request for documents regarding distributor product usage.
- Litigation: Ongoing class action lawsuits in California (Minton v. Herbalife) and West Virginia (Mey v. Herbalife) regarding marketing practices and telemarketing. A $7 million settlement in the West Virginia case is pending final court approval.
- China Operations: Expansion in China is subject to significant regulatory risk, including the need to obtain direct selling licenses and compliance with evolving local laws. The company operates a different business model in China (retail stores/employed sales force) compared to its global network marketing model.
Investor Verification Checklist
- Distributor Turnover: Verify the sustainability of sales growth given the high turnover rate inherent in the network marketing model and the recent decline in new supervisors in key markets like Brazil and Mexico.
- China Regulatory Status: Monitor the progress of direct selling license approvals in China, as the company's growth strategy relies heavily on expanding beyond the current Jiangsu province licenses.
- Legal Reserves: Review the adequacy of reserves for pending litigation (Minton, Mey) and tax audits, particularly given the company's assertion that adverse outcomes are not expected to be material.
- Debt Covenants: Confirm compliance with financial covenants in the $300 million senior secured credit facility, especially regarding leverage ratios and restricted payments.
- Product Concentration: Assess the risk associated with the Formula 1 meal replacement product, which historically accounts for a significant portion of retail sales.